Acepodia, Inc. (6976)
TWSE
Closed
Aug 25, 2026
Day's Range
11.6552 wk Range
10.85Overview - 6976 - Acepodia, Inc.
Key Statistics
Valuation
Enterprise Value
3.80B
P/E (Trailing)
‪61.21‬
Price / Sales (TTM)
‪37,318.57‬
Price / Book
‪1.41‬
EV / EBITDA
‪-4.00‬
Profitability
Profit Margin
‪65.40%‬
Operating Margin
‪-409,336.21%‬
Return on Assets
‪-11.35%‬
Return on Equity
‪-15.77%‬
Ownership
Shares Outstanding
582.21M
Float
298.70M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.03%‬
Price stats
50-Day Avg
‪12.55‬
200-Day Avg
‪13.44‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6976 - Acepodia, Inc.
Peers - 6976 - Acepodia, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6976TWSEAcepodia, Inc.6.99BMarket Cap-28.22%52-week change61.21P/E (Trailing)‪65.40%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.80.61BMarket Cap+68.42%52-week change-170.12P/E (Trailing)‪-13.97%‬Profit Margin
- 6696TWSELin BioScience, Inc.77.69BMarket Cap+83.89%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.24.18BMarket Cap+66.02%52-week change—P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.22.82BMarket Cap-54.32%52-week change384.62P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.83BMarket Cap-2.00%52-week change30.17P/E (Trailing)‪35.54%‬Profit Margin
Profile Summary - 6976 - Acepodia, Inc.
About
Acepodia, Inc. is a clinical-stage biotechnology company specializing in pioneering cell therapies aimed at transforming cancer treatment. The company's primary focus lies in its proprietary Antibody-Cell Conjugation (ACC) platform, a technology that directly links tumor-targeting antibodies to immune cells such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
